← Back to Clinical Trials
Recruiting NCT05606731

NCT05606731 Family Intervention to Prevent Childhood Obesity

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05606731
Status Recruiting
Phase
Sponsor University of California, Los Angeles
Condition Childhood Obesity
Study Type INTERVENTIONAL
Enrollment 182 participants
Start Date 2023-11-06
Primary Completion 2026-09-30

Eligibility & Interventions

Sex All sexes
Min Age 2 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Family-Based Childhood Obesity Intervention

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 182 participants in total. It began in 2023-11-06 with a primary completion date of 2026-09-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Consumption of sweetened beverages, media-viewing, and physical activity patterns are often established during early childhood, and family-based obesity interventions show effectiveness in shaping healthy behaviors and weight outcomes for young children, including Latino children. Missing from these interventions, however, are methods to increase accessibility and dissemination to multiple family caregivers. The proposed work will use a randomized study design to evaluate the impact a family-based early childhood obesity intervention for Latino families that incorporates evidence-based strategies of in-person childhood obesity interventions, mobile phones, and leverages important determinants of Latino health (e.g. familism, language) in order to decrease ethnic disparities in childhood obesity and cardiovascular risk.

Eligibility Criteria

Inclusion Criteria: Adult caregivers of a young child who: * self-identify as an individual of Latino descent * have a 2- to 5-year-old child/grandchild who is overweight or obese, defined as having a BMI\>85% for age and sex * lives with or cares for the child at least 20 hours per week (the relationship does not have to be biological * speaks Spanish or English * ability and willingness to participate in the intervention (determined with a Subject Comprehension and Participation Assessment Tool) * agrees to complete baseline, 1-, 6-, 12-month post-intervention data collection protocols Exclusion Criteria: Caregivers of a child with: * medical conditions related to overweight status such as Prader-Willi Syndrome * taking weight loss medication * participating in a weight loss program.

Contact & Investigator

Central Contact

Alma D Guerrero, MD, MPH

✉ aguerrero@mednet.ucla.edu

📞 (310) 267-2789

Frequently Asked Questions

Who can join the NCT05606731 clinical trial?

This trial is open to participants of all sexes, aged 2 Years or older, studying Childhood Obesity. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT05606731 currently recruiting?

Yes, NCT05606731 is actively recruiting participants. Contact the research team at aguerrero@mednet.ucla.edu for enrollment information.

Where is the NCT05606731 trial being conducted?

This trial is being conducted at Los Angeles, United States.

Who is sponsoring the NCT05606731 clinical trial?

NCT05606731 is sponsored by University of California, Los Angeles. The trial plans to enroll 182 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology